2019 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ - ICKSH 2019 (3¿ù 14ÀÏ) : 2019-03-14±³À°ÀÏÀÚ : 2019-03-14
±³À°Àå¼Ò : ±×·£µå¿öÄ¿ÈúÈ£ÅÚ ºñ½ºÅ¸È¦
±³À°ÁÖÁ¦ :
2019 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ - ICKSH 2019 (3¿ù 14ÀÏ)ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581
À̸ÞÀÏ :
hematology@kams.or.kr ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 8 ½Ã°£ 25ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í Æç·Î¿ì, °£È£»ç, ¿¬±¸¿ø, Çлý, Àü°øÀÇ 50,000¿ø ºñȸ¿ø 200,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-14 VISTA 2 09:00~09:30 Paroxysmal noctural hemoglobinuria in bone marrow failure ÀåÁØÈ£(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 03-14 VISTA 2 09:30~10:00 Germline mutations in inherited bone marrow failure Jean Soulier(France)
±³À°½Ã°£ 03-14 VISTA 2 10:00~10:30 Telomere lenugh and somatic mutations in aplastic anaemia À̵¿¼ø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 03-14 VISTA 2 10:45~11:15 Appllication of CRISR/Cas-9 in blood dz marthew H Porteus(USA)
±³À°½Ã°£ 03-14 VISTA 2 11:15~11:45 Gene therapy in Hemophilia katherine Ann(USA)
±³À°½Ã°£ 03-14 VISTA 2 11:45~12:15 Stem Cell in human AML Ravindra Majeti(USA)
±³À°½Ã°£ 03-14 VISTA 2 12:15~12:45 Precision medicine in pedaitic acute lymphoblastic leukemia Ching-Hon Pui(USA)
±³À°½Ã°£ 03-14 VISTA 2 12:45~13:40 Optimal treatment sequencing for patients with relapsed/refractory multiple myeloma Ajai Chari(USA)
±³À°½Ã°£ 03-14 VISTA 2 13:40~14:00 CML in Phillipines priscilla Caguioa(Philippoines)
±³À°½Ã°£ 03-14 VISTA 2 14:00~14:20 Outcome of allogeneic hematopoietic stem cell transplantation for SAA and PNH at Vietnam national institute of haematology and blood transfusion Vo Thi Thanh Binh(Vietnam)
±³À°½Ã°£ 03-14 VISTA 2 14:20~14:40 Hemoglobinopathy in Thailand Suradej Hongeng(Thailand)
±³À°½Ã°£ 03-14 VISTA 2 14:55~15:25 Strategy to overcome treatment resistance in high risk multiple myeloma Lugui Qiu(China)
±³À°½Ã°£ 03-14 VISTA 2 15:25~15:55 Roles of bone marrow microenvironment in clonal evolution and drug resistance of multiple myeloma Yusuke Furukawa(japan)
±³À°½Ã°£ 03-14 VISTA 2 15:55~16:25 Antigen-mediated regqulatin in MM Madhav Dhodapkar(USA)
±³À°½Ã°£ 03-14 VISTA 2 16:40~17:10 Progress in gene therapy for hemophilia A and B Blenn F Pierce(USA)
±³À°½Ã°£ 03-14 VISTA 2 17:10~17:40 Individualized treatment for hemophilia : Population pharmacokinetics approach Cindy H. T. Yeung(Canada)
±³À°½Ã°£ 03-14 VISTA 2 17:40~18:10 Mechanisms of cancer-associated thrombosis Nigel mackman(USA)